Am. J. Respir. Crit. Care Med., Vol 153, No. 5, 05 1996, 1548-1552.
Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data
DM Mannino, RA Etzel and RG Parrish
Air Pollution and Respiratory Health Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
We sought to describe pulmonary fibrosis mortality in the United States
from 1979 through 1991 by analyzing death certificate reports compiled by
the National Center for Health Statistics. Of the 26,866,600 people who
died during the study period, 107,292 had a diagnosis of pulmonary fibrosis
listed on their death certificates. Among men, age-adjusted mortality rates
increased from 48.6 per 1,000,000 in 1979 to 50.9 per 1,000,000 in 1991
and, among women, these rates increased from 21.4 per 1,000,000 in 1979 to
27.2 per 1,000,000 in 1991. Among both men and women rates were higher in
older age strata than in younger age strata. Age-adjusted mortality rates
were consistently higher among whites and people of races than blacks. The
frequency with which pulmonary fibrosis was listed as the underlying cause
of death increased from 40% in 1979 to 56% in 1991. Age-adjusted mortality
rates varied by state, with lowest rates in the Midwest and Northeast, and
the highest rates in the West and Southeast. We conclude that the
age-adjusted rate of pulmonary fibrosis among decedents in the United
States increased, and pulmonary fibrosis was listed as the underlying cause
of death with increasing frequency, over the study period. We cannot
determine whether the differences we detected between regions, sexes, and
races are related to characteristics of the disease or problems in death
certification and coding.
This article has been cited by other articles:

|
 |

|
 |
 
M. K. Han, S. Murray, C. D. Fell, K. R. Flaherty, G. B. Toews, J. Myers, T. V. Colby, W. D. Travis, E. A. Kazerooni, B. H. Gross, et al.
Sex differences in physiological progression of idiopathic pulmonary fibrosis
Eur. Respir. J.,
June 1, 2008;
31(6):
1183 - 1188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Olson, J. J. Swigris, D. C. Lezotte, J. M. Norris, C. G. Wilson, and K. K. Brown
Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
Am. J. Respir. Crit. Care Med.,
August 1, 2007;
176(3):
277 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Raghu, D. Weycker, J. Edelsberg, W. Z. Bradford, and G. Oster
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
October 1, 2006;
174(7):
810 - 816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gharaee-Kermani, K. Hatano, Y. Nozaki, and S. H. Phan
Gender-Based Differences in Bleomycin-Induced Pulmonary Fibrosis
Am. J. Pathol.,
June 1, 2005;
166(6):
1593 - 1606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. MIYAKE, S. SASAKI, T. YOKOYAMA, K. CHIDA, A. AZUMA, T. SUDA, S. KUDOH, N. SAKAMOTO, K. OKAMOTO, G. KOBASHI, et al.
Occupational and Environmental Factors and Idiopathic Pulmonary Fibrosis in Japan
Ann. Hyg.,
April 1, 2005;
49(3):
259 - 265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Enomoto, J. Usuki, A. Azuma, T. Nakagawa, and S. Kudoh
Diabetes Mellitus May Increase Risk for Idiopathic Pulmonary Fibrosis
Chest,
June 1, 2003;
123(6):
2007 - 2011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Moore, M. Peters-Golden, P. J. Christensen, V. Lama, W. A. Kuziel, R. Paine III, and G. B. Toews
Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2
Am J Physiol Lung Cell Mol Physiol,
February 1, 2003;
284(2):
L342 - L349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Saydain, A. Islam, B. Afessa, J. H. Ryu, J. P. Scott, and S. G. Peters
Outcome of Patients with Idiopathic Pulmonary Fibrosis Admitted to the Intensive Care Unit
Am. J. Respir. Crit. Care Med.,
September 15, 2002;
166(6):
839 - 842.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Selman
Idiopathic Pulmonary Fibrosis Challenges for the Future
Chest,
July 1, 2001;
120(1):
8 - 10.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Demedts, A.U. Wells, J.M. Anto, U. Costabel, R. Hubbard, P. Cullinan, H. Slabbynck, G. Rizzato, V. Poletti, E.K. Verbeken, et al.
Interstitial lung diseases: an epidemiological overview
Eur. Respir. J.,
July 1, 2001;
18(32_suppl):
2S - 16s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Selman, T. E. King Jr., and A. Pardo
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
Ann Intern Med,
January 16, 2001;
134(2):
136 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Michaelson, S. M. Aguayo, and J. Roman
Idiopathic Pulmonary Fibrosis : A Practical Approach for Diagnosis and Management
Chest,
September 1, 2000;
118(3):
788 - 794.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. King
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement
Am. J. Respir. Crit. Care Med.,
February 1, 2000;
161(2):
646 - 664.
[Full Text]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|